drug · small molecule
IDOSE TR
updated 5mo agoby $GKOS GLAUKOS Corp🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 5Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 2 investigational indications.
targets
Prostaglandin F2-alpha receptor
all catalysts(0)
nothing on the calendar yet
Trials studying IDOSE TR
- —iDose TR Administration in an Office-Based Surgery Setting
- phase2Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- phase2A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)
- phase4Travoprost Intraocular Implant + iStent Infinite
- phase3Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- —Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
- phase4Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
- phase4Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that